NateraNatera Facebook ad: “Access therapy response before surgery”
Ran for 31 days, from May 8 to June 8, 2026, the last day Crush saw it.
Run by Natera on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 949133734667270
- Platforms
- Facebook, Instagram, Messenger, WhatsApp and Threads
- Relaunches
- 0
Ad text
Determine which patients have responded to therapy before surgery
Where the ad sends people
natera.com
Access therapy response before surgery
Signatera™ is a sensitive ctDNA test for colorectal cancer that can identify relapse sooner than standard tools. Click here to learn more about it.
Learn more: natera.com(opens in a new tab)
